QL
STOK icon

Quarry LP’s Stoke Therapeutics STOK Stock Holding History

Quarry LP’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Buy
+478
New +$15.3K ﹤0.01% 878
2025
Q4 		– Sell
-956
Closed -$22.5K – 2594
2025
Q3 		$22.5K Buy
+956
New +$16.4K ﹤0.01% 1330
2024
Q3 		– Sell
-118
Closed -$1.59K – 2062
2024
Q2 		$1.59K Buy
+118
New +$1.59K ﹤0.01% 1659

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Quarry LP's STOK Position: Q2 2026 in Review

Quarry LP opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 478 shares worth $15.6K. The stake represents ﹤0.01% of the portfolio and ranks #878 among its holdings. This is a return to the name: Quarry LP previously reported a position in STOK as recently as Q3 2025.

Quarry LP first reported a position in STOK in Q2 2024 and has held it in 3 quarters since. The position peaked at $22.5K in Q3 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Quarry LP held 478 shares of Stoke Therapeutics worth $15.6K as of Q2 2026.
  • Stoke Therapeutics was a new Quarry LP position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #878 holding.
  • Quarry LP first reported a position in Stoke Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Quarry LP's Stoke Therapeutics position peaked at $22.5K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.